These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7536607)

  • 21. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
    Pal RP; Thiruudaian T; Khan MA
    Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between the serum level of prostate specific antigen and bone and CT scans in the staging of the primary carcinoma of the prostate].
    Hoefman E; Hulshof MC; de Reijke TM; Bruijnes E; Redekop WK; van Straalen JP
    Ned Tijdschr Geneeskd; 1998 May; 142(20):1142-6. PubMed ID: 9623236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical utility of prostate-specific antigen and bone scintigraphy in prostate cancer follow-up.
    Freitas JE; Gilvydas R; Ferry JD; Gonzalez JA
    J Nucl Med; 1991 Jul; 32(7):1387-90. PubMed ID: 1712383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients.
    Zissimopoulos A; Bantis A; Stellos K; Petrakis G; Matthaios D
    J BUON; 2008; 13(1):69-74. PubMed ID: 18404790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
    Murphy GP; Troychak MJ; Cobb OE; Bowes VA; Kenny RJ; Barren RJ; Kenny GM; Ragde H; Holmes EH; Wolfert RL
    Prostate; 1997 Oct; 33(2):141-6. PubMed ID: 9316655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer.
    Miller PD; Eardley I; Kirby RS
    Br J Urol; 1992 Sep; 70(3):295-8. PubMed ID: 1384920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J; Lorente JA; Encabo G
    Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
    Vijayakumar V; Vijayakumar S; Quadri SF; Blend MJ
    Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL; Wang XF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The indication of bone scan for patients with newly diagnosed prostate cancer].
    Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of bone metastasis in men with prostate cancer by measurement of serum ICTP in combination with alkali phosphatase and prostate-specific antigen.
    Kataoka A; Yuasa T; Kageyama S; Tsuchiya N; Habuchi T; Iwaki H; Narita M; Okada Y; Yoshiki T
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):480-4. PubMed ID: 16909972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of serum prostate specific antigen levels and bone scintigraphy in patients with prostate carcinoma].
    Bielickaite J; Zadeikaite R; Jurkiene N; Kiudelis J; Kuprionis G
    Medicina (Kaunas); 2003; 39(9):867-71. PubMed ID: 14515049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer.
    Noguchi M; Yahara J; Noda S
    Urology; 2003 May; 61(5):993-8. PubMed ID: 12736022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
    Lin K; Szabo Z; Chin BB; Civelek AC
    Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
    Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
    Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy.
    Terris MK; Klonecke AS; McDougall IR; Stamey TA
    J Nucl Med; 1991 Sep; 32(9):1713-7. PubMed ID: 1715394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of prostate-specific antigen levels and patterns of benign and malignant uptake detected. on bone scintigraphy in patients with newly diagnosed prostate carcinoma.
    Jacobson AF
    Nucl Med Commun; 2000 Jul; 21(7):617-22. PubMed ID: 10994663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.